Effectiveness and safety of vitamin K antagonists and new anticoagulants in the prevention of thromboembolism in atrial fibrillation in older adults - a systematic review of reviews and the development of recommendations to reduce inappropriate prescribing.

Christina Sommerauer, Lisa Schlender, Marc Krause, Sabine Weißbach, Anja Rieckert, Yolanda V Martinez, David Reeves, Anna Renom-Guiteras, Ilkka Kunnamo, Andreas Sönnichsen

Journal: BMC geriatrics 2018;17(Suppl 1):223

PMID: 29047348

Free Full Text on BioMed Central View on PubMed

Abstract

Address: Institute of General Practice and Family Medicine, University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448, Witten, Germany. [email protected].; Institute of General Practice and Family Medicine, University of Witten/Herdecke, Alfred-Herrhausen-Straße 50, 58448, Witten, Germany.; NIHR School for Primary Care Research, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.; Department of Geriatrics, University Hospital Parc de Salut Mar, Barcelona, Spain.; Duodecim Medical Publications Ltd, Helsinki, Finland.

DOI: 10.1186/s12877-017-0573-6

Link outs

Free resources

Full Text Sources:

Medical:

https://medlineplus.gov/bloodthinners.html

Other Literature Sources:

https://scite.ai/reports/29047348

MeSH Terms: Administration, Oral, Anticoagulants, Atrial Fibrillation, Clinical Decision-Making, Fibrinolytic Agents, Humans, Inappropriate Prescribing, Review Literature as Topic, Stroke, Thromboembolism, Treatment Outcome, Vitamin K